In this regard, Vismodegib, one of the SMO antagonists, appears to downregulate the expression level of Gli1, Hedgehog Interacting Protein (Hhip), and Ptch1 especially in the stroma to suppress HH signaling and tumor growth. This evidence concerns the gene SMO and neoplasm.